view counter
 
view counter
 
 

Notices Regarding Levamisole, EIPH

Published: October 30, 2018 1:22 pm ET

No Comments | Jump to Comments

On Tuesday (Oct. 30), the Canadian Pari-Mutuel Agency issued a pair of notices, one in regard to the use of Levamisole and the other in regard to provincial Exercise-Induced Pulmonary Hemorrhage lists.

In regard to Levamisole, the CPMA is reminding veterinarians and racehorse trainers and owners that Levamisole is a prohibited substance in Canada because it metabolizes into aminorex, a prohibited stimulant. Levamisole should not be administered to a racehorse for any reason.

To view the CPMA’s Levamisole notice, click here.

In regard to the provincial EIPH lists, the CPMA notice states that the agency has received an inquiry concerning the requirement for a horse to remain on a provincial EIPH list for 100 days, when the horse moves from one EIPH list to a new province’s EIPH list.

The CPMA has stated that Pari-Mutuel Betting Supervision Regulations require provincial commissions to maintain an up-to-date list of horses that participate in their EIPH program. Any horse on a province’s EIPH list is required to remain on that list for a period of at least 100 days.

To view the CPMA’s EIPH notice, click here.

(With files from the CPMA)


view counter
 
 
 

© 2018 Standardbred Canada. All rights reserved. Use of this site signifies your agreement and compliance with the legal disclaimer and privacy policy.

Firefox 3 Best with IE 7 Built with Drupal